ScopusElsevier Scopus
Status
Active
Coverage
1973–2026; 1970
Source type
Journal
Open access
No
CiteScore
0.6
Best quartile
Q4 · 13th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 242 / 278 | 13th | Q4 |
| Pharmacology | 287 / 328 | 12th | Q4 |
Adverse Drug Reaction Bulletin
ISSN 0044-6394 · 2159-7774
Publisher: Lippincott Williams and Wilkins
Scopus · Q4ONOS
Is Adverse Drug Reaction Bulletin indexed in Scopus? Yes — actively indexed in Scopus, coverage 1973–2026; 1970, best quartile Q4, CiteScore 0.6.
Is Adverse Drug Reaction Bulletin in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Adverse Drug Reaction Bulletin open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
0.6
CiteScore 2025
Scopus
Q4
Best quartile
13th percentile
1
Indexed in
major index
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.